(Q45456081)

English

Long-term neuroprotection achieved with latency-associated promoter-driven herpes simplex virus gene transfer to the peripheral nervous system

scientific article published in August 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Long-term neuroprotection achieved with latency-associated promoter-driven herpes simplex virus gene transfer to the peripheral nervous system (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

author name string

Munmun Chattopadhyay

1

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Darren Wolfe

2

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Marina Mata

3

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Shaohua Huang

4

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Joseph C Glorioso

5

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

David J Fink

6

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

publication date

1 August 2005

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Molecular Therapy

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

307-313

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Development and application of herpes simplex virus vectors for human gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.009

7 January 2021

Development and optimization of herpes simplex virus vectors for multiple long-term gene delivery to the peripheral nervous system

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.009

7 January 2021

Herpes vector-mediated gene transfer in treatment of diseases of the nervous system

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.009

7 January 2021

Protective effect of herpes simplex virus-mediated neurotrophin gene transfer in cisplatin neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.009

7 January 2021

Protective effect of HSV-mediated gene transfer of nerve growth factor in pyridoxine neuropathy demonstrates functional activity of trkA receptors in large sensory neurons of adult animals

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.009

7 January 2021

Bcl-2 and GDNF delivered by HSV-mediated gene transfer after spinal root avulsion provide a synergistic effect

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.009

7 January 2021

Herpes simplex-mediated gene transfer of nerve growth factor protects against peripheral neuropathy in streptozotocin-induced diabetes in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.009

7 January 2021

Peripherally delivered glutamic acid decarboxylase gene therapy for spinal cord injury pain

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.009

7 January 2021

Transgene-mediated enkephalin release enhances the effect of morphine and evades tolerance to produce a sustained antiallodynic effect in neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.009

7 January 2021

Herpes vector-mediated expression of proenkephalin reduces bone cancer pain

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.009

7 January 2021

Neurotrophin-3 administration attenuates deficits of pyridoxine-induced large-fiber sensory neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.009

7 January 2021

In vivo gene therapy for pyridoxine-induced neuropathy by herpes simplex virus-mediated gene transfer of neurotrophin-3.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.009

7 January 2021

Nerve growth factor prevents experimental cisplatin neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.009

7 January 2021

Nerve growth factor administration protects against experimental diabetic sensory neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.009

7 January 2021

Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: A randomized controlled trial. rhNGF Clinical Investigator Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.009

7 January 2021

Viral and non-viral gene therapy partially prevents experimental cisplatin-induced neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.009

7 January 2021

Intraputamenal infusion of GDNF in aged rhesus monkeys: Distribution and dopaminergic effects

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.009

7 January 2021

Continuous delivery of neurotrophin 3 by gene therapy has a neuroprotective effect in experimental models of diabetic and acrylamide neuropathies

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.009

7 January 2021

Deletion of multiple immediate-early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.009

7 January 2021

Multiple immediate-early gene-deficient herpes simplex virus vectors allowing efficient gene delivery to neurons in culture and widespread gene delivery to the central nervous system in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.009

7 January 2021

Comparative analysis of genomic HSV vectors for gene delivery to motor neurons following peripheral inoculation in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.009

7 January 2021

Herpes simplex virus type 1 ICP0 protein does not accumulate in the nucleus of primary neurons in culture

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.009

7 January 2021

Evidence for a bidirectional element located downstream from the herpes simplex virus type 1 latency-associated promoter that increases its activity during latency

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.009

7 January 2021

Enhancer and long-term expression functions of herpes simplex virus type 1 latency-associated promoter are both located in the same region

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.009

7 January 2021

Sequence determination and genetic content of the short unique region in the genome of herpes simplex virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.009

7 January 2021

Viral shedding and biodistribution of G207, a multimutated, conditionally replicating herpes simplex virus type 1, after intracerebral inoculation in aotus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.009

7 January 2021

Replication-defective herpes simplex virus vectors for gene transfer in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.009

7 January 2021

Safety and biodistribution studies of an HSV multigene vector following intracranial delivery to non-human primates

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.009

7 January 2021

Intrathecal interleukin-1 receptor antagonist in combination with soluble tumor necrosis factor receptor exhibits an anti-allodynic action in a rat model of neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.009

7 January 2021

The latency-associated promoter of herpes simplex virus type 1 requires a region downstream of the transcription start site for long-term expression during latency.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.009

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.YMTHE.2005.04.009

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45456081&oldid=2076964299"